A study following people with brain tumors treated with STaRT (GammaTiles)
Original title: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase was given for this study, so we treat it as an early stage test in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study collects information on how people with brain tumors do after treatment with STaRT, also called GammaTiles.
Who this trial is for. This study is for people with brain tumors who are treated with STaRT, also known as GammaTiles. It is a registry, which means it gathers information about how patients do after this treatment in everyday care.
Where it stands. There are no results yet. The study is looking at how well STaRT works, how safe it is, and what patients themselves report about how they are doing. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: If you or your loved one is facing treatment for a brain tumor, this study is one way information about STaRT is being collected. Someone who fits could ask their care team about it. The care team can explain if it makes sense in your situation.
What it doesn't mean: This does not mean STaRT is proven. A study is a test, not a treatment that has been shown to work. Joining a study is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, July 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.